Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
A Prospective Sub-Study of the Global Hypophosphatasia Registry
for
Hypophosphatasia
Location: Nashville TN, Columbus OH, Chicago IL, Kansas City MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT05234567
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Franklin TN, Birmingham AL, Atlanta GA, St Louis MO,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase2, Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Location: Brentwood TN, Lexington KY, Memphis TN, Atlanta GA,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT05963698
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Hermitage TN, Atlanta GA, Indianapolis IN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Smyrna TN, Bowling Green KY, Decatur GA,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase1, Phase2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Nashville TN, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Goodlettsville TN, Murfreesboro TN, Bowling Green KY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Hermitage TN, Anniston AL, Homewood AL, St Louis MO,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase2, Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: Nashville TN, Philadelphia PA, Boston MA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase1, Recruiting
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
for
Alzheimer Disease
Location: Brentwood TN
Sponsor: MaxWell Clinic, PLC
Sex: All
Age: 18+
Code: NCT06079827
Recruiting
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
for
Long COVID
Location: Brentwood TN
Sponsor: MaxWell Clinic, PLC
Sex: All
Age: 18+
Code: NCT06311435
Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)